Novartis AG

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
PFEPfizer Inc. 1.12%53.060.9%$1380.15m
JNJJohnson & Johnson 1.33%179.330.7%$1370.53m
BMYBristol-Myers Squibb Co. 1.05%76.991.0%$1209.85m
MRKMerck & Co., Inc. 0.60%94.110.7%$1146.47m
ABBVAbbVie, Inc. -0.99%149.521.9%$1126.89m
LLYEli Lilly & Co. 1.35%302.881.1%$904.24m
AZNAstraZeneca Plc 0.68%66.661.0%$521.16m
BHVNBiohaven Pharmaceutical Holding Co. Ltd. 0.87%143.260.0%$462.47m
VERUVeru, Inc. -1.79%13.140.0%$312.94m
NVSNovartis AG 1.43%90.700.2%$254.79m
GSKGlaxoSmithKline Plc 0.76%44.860.2%$245.02m
HZNPHorizon Therapeutics Plc -1.80%88.725.4%$196.78m
NVONovo Nordisk A/S 0.27%108.050.1%$191.26m
SGENSeagen Inc. 0.48%140.315.7%$182.62m
VTRSViatris, Inc. -1.31%11.650.0%$164.02m

Company Profile

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products, including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.